John Friend

John Friend

Director Ejecutivo en KAZIA THERAPEUTICS LIMITED .

54 años
Health Technology
Consumer Services

Perfil

John E.
Friend
is currently the Chief Executive Officer at Kazia Therapeutics Ltd.
Prior to his current position, he served as the Senior Vice President-Medical & Scientific Affairs at Helsinn Therapeutics (U.S.), Inc. from 2010 to 2017.
He then worked as the Chief Medical Officer & Vice President at Cellectar Biosciences, Inc. from 2017 to 2018, and again from 2020 to 2021.
Additionally, he held the position of Chief Medical Officer at Druggability Technologies Holdings Ltd.
(New Jersey).
Dr. Friend obtained his undergraduate degree from Southern Methodist University and his doctorate from Robert Wood Johnson Medical School.

Cargos activos de John Friend

EmpresasCargoInicio
KAZIA THERAPEUTICS LIMITED Director Ejecutivo 01/05/2023
Todos los cargos activos de John Friend

Antiguos cargos conocidos de John Friend.

EmpresasCargoFin
CELLECTAR BIOSCIENCES, INC. Director Técnico/Científico/I+D 02/11/2021
CELLECTAR BIOSCIENCES, INC. Director Técnico/Científico/I+D 27/11/2018
Director Técnico/Científico/I+D 01/04/2017
Druggability Technologies Holdings Ltd. (New Jersey) Director Técnico/Científico/I+D -
Ver el detalle de la experiencia de John Friend.

Formación de John Friend.

Southern Methodist University Undergraduate Degree
Robert Wood Johnson Medical School Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de John Friend.

Relaciones

22

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
CELLECTAR BIOSCIENCES, INC.

Health Technology

KAZIA THERAPEUTICS LIMITED

Health Technology

Empresas privadas2

Health Technology

Druggability Technologies Holdings Ltd. (New Jersey)

Ver las conexiones de la empresa
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA